Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04524052
What this trial is testing

To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19

Who this might be right for
Healthy
Daewoong Pharmaceutical Co. LTD. 32
Early research (Phase 1)Study completedNCT05418101
What this trial is testing

Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease)

Who this might be right for
Autoimmune Diseases
Otsuka Pharmaceutical Development & Commercialization, Inc. 61
Early research (Phase 1)Study completedNCT03211143
What this trial is testing

Compare PK, PD and Safety of CKD-381 in Healthy Subjects

Who this might be right for
GERD
Chong Kun Dang Pharmaceutical 41
Early research (Phase 1)Study completedNCT00965653
What this trial is testing

Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 29
Early research (Phase 1)Study completedNCT02777827
What this trial is testing

A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With Asthma

Who this might be right for
Asthma
AstraZeneca 30
Early research (Phase 1)Study completedNCT00610194
What this trial is testing

Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients

Who this might be right for
Advanced Cancer
Bayer 69
Early research (Phase 1)Study completedNCT02174237
What this trial is testing

Test the Safety/Tolerability of Increasing Doses of LNP1892 Versus Placebo in Healthy Male/Female Subjects

Who this might be right for
Healthy
Lupin Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT00541866
What this trial is testing

Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans

Who this might be right for
Acute Myeloid Leukemia
Sunesis Pharmaceuticals 110
Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT04346888
What this trial is testing

Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients

Who this might be right for
Myasthenia Gravis
Harbour BioMed (Guangzhou) Co. Ltd. 30
Testing effectiveness (Phase 2)Ended earlyNCT00607451
What this trial is testing

Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia

Who this might be right for
Levodopa-induced Dyskinesia
Neurim Pharmaceuticals Ltd. 8
Early research (Phase 1)Study completedNCT04366349
What this trial is testing

Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab (GSK3772847) in Healthy Participants

Who this might be right for
Healthy VolunteersAsthma
GlaxoSmithKline 65
Early research (Phase 1)Study completedNCT03279120
What this trial is testing

Safety, PK, and PD Study of IVRs Releasing TFV and LNG

Who this might be right for
Anti-Infective AgentsAnti-Retroviral AgentsContraceptive Usage
CONRAD 66
Early research (Phase 1)Study completedNCT01278108
What this trial is testing

First-in-Human Single Ascending and Multiple Dose of GLPG0778

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 40
Early research (Phase 1)Study completedNCT02146625
What this trial is testing

Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects

Who this might be right for
Healthy
HK inno.N Corporation 40
Testing effectiveness (Phase 2)Ended earlyNCT00779220
What this trial is testing

Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Chugai Pharmaceutical 152
Early research (Phase 1)Study completedNCT04258527
What this trial is testing

Phase 1 Study of Pemigatinib in Patients With Advanced Malignancies With FGF/FGFR Alterations

Who this might be right for
Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 12
Early research (Phase 1)Study completedNCT02870231
What this trial is testing

Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

Who this might be right for
Metabolism and Nutrition DisorderObesity
Novo Nordisk A/S 187
Early research (Phase 1)Study completedNCT04839120
What this trial is testing

PK, PD, Tolerability and Safety of MDPK67b in Healthy Volunteers

Who this might be right for
Prostatic Neoplasms
Med Discovery SA 8
Testing effectiveness (Phase 2)Ended earlyNCT01688882
What this trial is testing

Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment

Who this might be right for
Bullous Pemphigoid
Novartis Pharmaceuticals 20
Next Page